drugs

Roche Abandons AC Immune Collaboration Returns Drugs

📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅